Arkolith/Insider Trading/TPTX/Form 4

Hirmand Mohammad

EVP & Chief Medical OfficerTurning Point Therapeutics, Inc. (TPTX) · full profile →Form 4 · filed Feb 11, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$24K
Net Open-Market Flow
-$24K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 9, 2022Sell(S)669$36.30$24K7K
Feb 9, 2022Grant(A)15K—$041K
Feb 9, 2022Grant(A)19K—$026K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 9, 2022Grant(A)68K—$068K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-008980) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML